Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

Clinical trial NCT07155850 · RECRUITING

Trial details

NCT number: NCT07155850
Sponsor: BetaGlue Therapeutics SpA
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)Locally Advanced Unresectable

Start date: 2026-02-03
Primary completion: 2027-02-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.